Drug Development for Parasite-Induced Diarrheal Diseases

Dublin Core

Title

Drug Development for Parasite-Induced Diarrheal Diseases

Subject

Drug Development

Description

One of the top four contributors to the global burden of disease is diarrheal infections. Intestinal parasites are major causes of morbidity and mortality associated with diarrheal diseases in both the developed and developing world. Amebiasis is responsible for 50 million cases of invasive disease and 70,000 deaths annually in the world. Giardiasis has an estimated worldwide prevalence of 280 million cases annually. In developed countries, Giardia lamblia infects about 2% of adults and 6-8% of children. The prevalence of G. lamblia infection is generally higher in developing countries, ranging from 3% to 90%. Furthermore, giardial infections contribute substantially to the 2.5 million annual deaths from diarrheal disease

Creator

Anjan Debnath , - James H. McKerrow

Source

https://www.frontiersin.org/research-topics/3253/drug-development-for-parasite-induced-diarrheal-diseases

Publisher

Frontiers Media SA

Date

2017

Contributor

Baihaqi

Rights

Creative Commons

Format

PDF

Language

English

Type

Textbooks

Files

Citation

Anjan Debnath , - James H. McKerrow, “Drug Development for Parasite-Induced Diarrheal Diseases,” Open Educational Resource (OER) - USK Library, accessed May 21, 2024, http://uilis.usk.ac.id/oer/items/show/3003.

Document Viewer